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pylon' was eradicated in 16 patients with duodenal ulcer (80%). and 
in 9 patients with gastritis (45%). Both regimens were well tolerated, 
and there were no treatment discontinuations. Mild side effects were 
recorded in 4 patients (2 fium group A and 2 fium group B). 
Conclusion: Azithromycin, in a total dose of 3 g, with omepra- 
zole and with or without amoxicillin eradicate H. pylon' in 80% of 
patients with duodenal ulcer, and in 56% of patients with gastritis. 
mj Seven or Twelve Days Therapies Combining 
Omeprazole with Amoxicillin and 
Clarithromycin to Cure H. pylon' 
A. Burette ' , B. Ram& I ,  C. Deprez I ,  Y. Glupczynski '. ' Clinique 
de la Basilique, Brussels, Belgium, 'A.  Vbsale Hospital, Charlemi, 
Belgium 
Objective: To evaluate the efficacy of a anti-H. pylon' (Hp) triple 
therapy with Omeprazole (OM) 20 mg bid, Amox 1 g bid and Clari 
500 mg tid given for 7 (OAC7) or 12 (OAC12). 
Methods: Single-blind, cohort study in an out-patient clinic. 100 
consecutive dyspeptic patients (pts) with or without Hpassociated 
ulcer &ease (PUD) were included in this study. 50 pts were given 
AOC12 and 50 others received AOC7. Endoscopy was performed 
before and 4-6 weeks post-Tx. The presence of Hp was assessed in 
antral and body biopsies by urease test, histology and culture with 
susceptibility testing to h i .  Eradication was defined as the absence 
of H p  in all post-Tx biopsies. Pts were considered compliant if they 
had taken 280% of the drugs. 
Results: Demographic and clinical data were similar in both 
groups. Eradication of H p  was confirmed by a negative 13C-UBT 
in all 51 pts (32 fium OAC12; 19 fium OAC7) who presented at 
the 3-6 month follow-up. Overall, mild side effects were reported 
by 25% of all pa whatever the drug regimen; 3 pts (2 in AOC12, 
1 in AOC7) discontinued therapy because of severe intolerance or 
allergic reaction. 
Tx Drop out Complrlnce Endmtlon PP Endxacion ITT 
>80% (95% CI) (95% CI) 
OAC1210/50 39/40 37/39 38/50 
95% (8S100) 76% (6G38) 
93% (85-100) 80% (69-91) 
OAC75/50 43/45 40143 40150 
Conclusion: Triple therapy with OM, Amox and Clari during 
7 days proved as effective as the same treatment given for 12 days, 
achieving a high eradication rate (>90%) in PP angysis. 
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I P954 I Seroprevalence of Hepatitis A in a Region from 
the Northwest of Spain (Fend, Galicia) 
J. Fernindez-Quintairos, M.I. UrsGa, A. Agulla. Sm'cio de 
Minobioloxia, Complex0 Hospitalan'o A. Marcide-Prof: N. Santos, Ferrol, 
Spain 
Objectives: To determine the seroprevalence of hepatitis A virus 
(HAV) in the region of Ferrol (Galicia, Northwest Spain). 
Methods: Subjects were recruited randomly h m  patients aged 1 
to 95 years who visited our Hospital ward during 1996 (n = 736), 
according to population age (nine groups) and sex distributions. 
HAV assesment was performed in a serum sample by Enzymun-Test 
Anti-HAY Boehringer Mannheim. 
Results: Overall, the HAV antibody seroprevalence was 62.4%. 
There was an increase related to age: 1.4% in the 1-9 years group; 
9.9% in 10-19; 43.2% in 20-29; 81.1% in 30-39; 92.7 in 40-49; 
100% in 50-59; 100% in 60-69; 97.7% in 7C-79 and 100% in >80 
years group. There were not differences by sex. 
Conclusions: HAV antibody semprevalence was highest over 50 
years of age. Therefore, HAV antibody determination could be ex- 
cluded fium screening in acute hepatitis patients of this group of age. 
Subjects aged 10 to 30 years were the most susceptible group for an 
HAV infection. Our youngest population (that is, under 10 years of 
age) could benefit b m  HAV vaccination. 
Hepatitis A Virus (HAV) Prevalence in Argentina 
0. Fay, A. Gentile, A. Manterola, M. Tregnaghi, I. Badia, J. Tanaka, 
R .  Ruttiman, M. Calvari, P Lamy A. Parra, H. Garrahan, 
R .  Gutierrez. Buenos A i m ,  H. Infantil, Cbrdoba y CTSP Univ. Nac. 
de Rosario, Argentina 
Hepatitis A is the most common cause of hepatitis in Argentina but 
the actual prevalence is not known. 
Objectives: to determine AntiHAV IgG in a not randomized 
sample of 1-40 years subjects in Cdrdoba and Buenos Aires, Ar- 
gentina and to associate its prevalence to age and socioeconomical 
level. 
Methods: 1) Data about age, education, overcrowdmg, water and 
sewage, were collected on an epidemiological form. 2) Blood sam- 
ples were taken fium every subject to detect AntiHAV (IgG Anti- 
HAV ELISA, Abbott, Chicago). 3) A socioeconomical level score 
(Centro de Estudios Demogrificos y de Desarrollo Urban0 of Mex- 
ico-modified) was used to asses the collected data. 4) Data was anal- 
ized using EPIINFO V6.03, statistical test (ch square-Yates correc- 
tion, and RR - 95% CI) were performed. 
Results: the overall AntiHAV IgG prevalence was 49.6% 
(377/759) in Buenos A i r e s  and 59.6% (452/759) in Cdrdoba. The 
age prevalence in Buenos Aires arises to 27.5% (1-5 yrs.) to 77.3% 
(36-40 yrs.), in Cdrdoba the prevalence was higher: 51% (1-5 yrs. )  
to 94.4% (36-40 yrs.). Risk factors associated with high prevalence 
of AntiHAV IgG were: a) Lack of drinking-water (p = 0.0006, 
RR = 1.2 (1.09-1.32)); b) Inappropriate s m g e  (p = 0.00000, RR 
= 1.38 (1.24-1.53)). c) Overcrowding (p = 0.00000, RR = 1.34 
(1.2-1.5)). -d) Low socioeconomical levels (p = 0.0000). e) Low ed- 
ucational levels (p = 0.04, R R  = 1.11 (1.01-1.22)). 
Conclusions: AniiHAV IgG prevalence in both cities is interme- 
diate and related to social factors. T h  findings should be taken into 
account to determine vaccination policy decisions in Argentina. More 
extensive epidemiological survey must be done in merent areas of the 
country in order to conclude about the actual attack rate. 
I P956 I HAV Antibodies in Indonesian Neonates and 
Children 
R. Vranckx. Institute of Hygiene and Epidemiolon, Brussek, Belgium 
Objectives: Five different epidemiological patterns (very hgh, high, 
intermediate, low and very low) become apparent when incidence 
rates and age-spec& antibodies to HAV (anti-HA) prevalences are 
examined. In this study we evaluate the age distribution of the preva- 
lence of immunity to HAV in neonates and very young Indonesian 
children. 
Materials and Methods: The study population (N = 153) in- 
cluded neonates, fium the Bandung area (Indonesia), who were fol- 
lowed up during 60 months. Sera were collected at birth and at 
months 1, 2, 12, 14, 24,36, 48 and 60. The HAV antibodies were 
determined by radioimmunoassay. 
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Results: At birth almost all the children (96.8%) were anti-HA 
positive, antibodies passively acquired h m  their mothers. They all 
became negative in the following 12 months. At the age of one year 
0.9% of the infants showed a positive serology for anti-HA. The 
numbers of children who acquired a natural immunisation by HAV 
infections rose to 4.7% at the age of 2, 11.4% at 3, 20.3% at 4 and 
finally 36.4% at the age of 5. 
Discussion: Indonesia shows the pattern of an high endemicity 
area. More improvements in public health and sanitation can raise 
the age of infection in Indonesia. This epidemiological shift can 
increase the probability of future epidemics of HAV in groups previ- 
ously protected by immunity acquired in early chddhood. This new 
epidemilogical pattern may have chical and public health implica- 
tions, since the existence at older age of relatively large groups of 
unprotected individuals living in an enmnment  that is still quite 
contaminated. 
[p957j Seroepidemiological Study of Hepatitis A in 
Southwestern Greece 
M. Christofidou, E Paliogianni, M. Skoutari, E. Economopoulou, 
G. Dimitracopoulos. Dep, ofMicrobiology, Sch. ofMedicine, Un. of 
Pafras, Greece 
Objectives: Infection with hepatitis A virus (HAV) remains a sign& 
icant health problem worldwide. A seroprevalence study of hepatitis 
A was performed in University Hospital of Patras during the last four 
years (1993-1996). 
Methods: Sera obtained h m  3861 (53%) men and 3475 (47%) 
women were tested for anti-HAV IgG and IgM antibodies by 
Elisa (Abbott USA, Sorin Italy). Children under two years old and 
blood-transfusion recipients were excluded h m  the study. 
Results: The persons examined were assigned to two age groups, 
(A) 1025 children 2-15 ys old, and (B) 6311 adults 16-65 ys old. In 
group A 239 (23%) subjects were IgG positive and among them 31 
(3%) were also IgM positive. In group B 4905 (77.5%) subjects were 
anti-HAV IgG positive and only 37 (0.5%) developed acute hepatitis 
and were IgM positive. 
Conclusions: The high percentage (77%) of children negative 
for anti-HAV IgG antibodies coupled with the fact that most of the 
adults (77.5%) had developed protective immunity against HAV sug- 
gests that OUT area has shifted h m  hgh endemic to interrnedmte-low 
endemic status for hepatitis A infection. The great number of sus- 
ceptible children is a potential risk for the development of a serious 
prolonged icteric infection during the adulthood. In this context, 
immunization against HAV might be considered to be performed 
during the first years of Me. 
Lp958/ Prevalence of HAV Antibodies in the Flemish 
R. Vrancla ', M. Beutels ', P. Van Damme *, A. Meheus '. 
'Institute ofHygiene and Epidemiology, Brussels, Belgium, 'University of 
An-, Antwerp, Belgium 
Objectives: In this study we evaluated the prevalence of HAV anti- 
bodies in the Flemish population of Belgium, to determine at which 
age pre-vaccination testing is useful and to analyse any change in the 
epidemiology pattern of HAV in Flanders. 
Materials and Methods: In 1993-94 we collected 4058 serum 
samples h m  a random sample of the general population. The sero- 
logical screening for anti-HAV was done using the HAVAB RIA kit 
(Abbott). 
Results: We found an anti-HAV seroprevalence of 52.5% among 
Belgians (N = 3186). Among non-Begians (N = 245) the anti-HAV 
Population of Belgium 
prevalence was sigtllficantly higher: 62%. Among BeJg~ans, we found 
a se ropdence  of 5.4% in the youngest age group (0-14) and 
a seroprevalence of more than 80% in the two oldest age groups 
(55-64 and >65). 
Discussion: The age-specific prevalence data reflect two merent 
epidemiological patterns: for Bebans an epidemiological pattern of 
a low endemic region and for non-Belgians an epidemiological pm- 
file of an intermediate endemic region. The prevalence data demon- 
strate that pre-vaccination testing for anti-HAV make vaccination 
reducdant in more than half of the population over 35 years of age. 
Compared to anti-HAV prevalence data fium 1979 and 1989, a clear 
epidemiological shifr with decreasing anti-HAV prevalence in the 
youngest age groups was found. 
I P959 The Seroprevalence of the "Total" Anti-HAV 
Antibody in the Czech Republic 
J. Beran, F! Douda, R. Prymula, M. spliiio. l'urkyne Military Medical 
Academy, Hradec Krhlovb, Czech Republic 
Objectives: To obtain data about the seroprevalence of hepatitis A 
antibody in the Czech population aged 15-55 years and compare 
them with data h m  previous study. 
Methods: The serum samples have been investigated by the 
MEIA (Microparticle Enzyme Immunoassay) in the fully automated 
system IMX. We used the Havab testing kits of the Abbott company. 
We obtained and investigated 91 1 serum samples fium the volunteers 
(female-441 and male-470) aged 15-55 years h m  a e r e n t  regions 
of the Czech Republic. The samples were dwided into four age 
cohorts by 10 years. 
Resulw. 
Semprevalcnce (%) of the ulti-HAV antibody in the Czech populanon and in the IFOR 
-0P 
Agccohora Male Female Male+FemaIe CZIFOR 
2G29 3.0 1.5 2.4 18.1 
30-39 10.3 13.5 11.8 36.1 
44-49 32.3 35.2 34.0 47.1 
50-59* 37.5 66.7 55.0 72.7 
AWlgc 13.9 33.2 
* NO differences ( s d  mount of the serum samp~a n = 20. n = 11 rerp.) 
Conclusions: 
(1) The seroprevalence of the "total" anti-HAV antibody: 
(a) Is very low (13.9%) in the Czech population aged 15-55. 
@) Is no higher than 2% in age cohort 15-20. 
(c) Increases with age in the male, female and IFOR cohorts, 
=P. 
(d) Is statisticaly higher in the Czech IFOR troop (group with 
higher risk of the aquisition of the HAV) than the seropreva- 
lence in age cohorts of the Czech population. 
(2) There are no Herences between genders in the seroprevalence 
of the anti-HAV antibody 
(3) The low seroprevalence of anti-HAV antibody in lower age co- 
horts is reason for current spread of HAV among schoolchildren. 
Ip960/ Hepatitis A in Adults 
V Nikolova, T. Dimimva, K. Pandieva. Chair OfInfeCous Diseases, 
Medical Faculty, So&, Bukaria 
Hepatitis A virus has a worldwide distributlon and causes clinical 
disease more fRquentIy in children than adults. The severity of the 
disease ranges fium subclinical infection to fulminant hepatitu and 
death and depends on the age of the subject. No tnnsition to chronic 
active hepatitis is observed, however in up to 15% relapse occurs. 
Hepatitis B and miscellaneous 235 
Immunization against hepatitis A is now recommended by the World 
Health Organization in subjects at risk of exposure to HAS? 
The aim of this study is to show that the acute madestations 
of HAV infection can be severe with prolonged clinical course and 
relapsing forms. 
476 patients with AVH were treated in the Infectious Diseases 
Hospital during 1995 last year. 305 /64.08%/ were with AVH A. 
Clinical signs and symptoms, liver &orders, biochemical mark- 
erdbilirubin, ASAT, ALAT, akphosphatase, B-lipoproteins, fibrino- 
genlwere analysed in 68 patients, aged 4C-71 years presenting seri- 
ous and long course of the disease with hgh  levels of bllirubinaemia 
1126-428 mkmol/l, /and serum increased transaminases activities 
/ASAT 224818 UIA, ALAT 402-1179 UI/l. Signs of cholestasis 
were in 48.52%, acute cholecystitis and cholangitis in 8 p. Fulm- 
nant form with encephalopathy developed in one 44 years old man, 
in contact with his child with AVH A. The patients were treated 
from 20 to 37 days in the hospital. Normalising of the biochemical 
changes at the time of &charge was in 70%. One month later ab- 
normal ASAT and ALAT levels were found in 11 patients. Relapse 
was in 3 patients with alcohol abuse. 
Conclusion: The acute HAV mfection is severe in adults and 
complications may develop. 
HAV RNA replication and polyprotein processing have not been 
demonstrated in infected cells. 
Methods: Using the fast growing HAVstrain HAS-15 short term 
kinetics were performed for the analysis of RNA and protein synthe- 
sis. An ELISA against viral capsids was undertaken and polyprotein 
processing was investigated by immunoblot using specific rabbit or 
guinea pig antisera. Synthesis of viral minus- and plus-strand FWA 
was followed by RT-PCR using primers of the 5' noncoding region 
of the genome. 
Results: Via ELISA viral antigen was detected starting 48 h after 
infection. Simultaneously with the appearance of viral capsids the 
viral proteinase 3C was detected together with the individual capsid 
proteins WO, VP1 and W3. Precursors of structural and functional 
proteins were found subsequently. Plus-strand RNA synthesis ap- 
peared 6 h after mfection, minus-strand RNA appeared 2 h later. 
During the first days of infection plus-strand RNA was found in a 
100 fold higher concentration than minus-strand RNA. 
Conclusions: From our results we conclude that RNA synthesis 
starts early on after infection although HAV grows slowly in cell 
culture. Polyprotein processing seems to be initiated by viral pro- 
teinase 3C which is detected prior to its precursors and those of the 
structural proteins. 
I P961 I Prediction of Hepatitis A Morbidity and 
Quantitative Evaluation of 
Enzymoimmunoassay's Results 
D.E. Toropov, PI. Ogarkov, A.R. Volgm, VS. Tokmakov. 
Military-Medical Academy, Saint-Petusburg, Russia 
In 19961995 the Diagnostic Center in Samara performed enzy- 
moimmunoassay in 2139 patients with hepatits A (HA) using di- 
agnostic preparations and equipment made by Roche Diagnostic 
(Switzerland). Anti-HAVIgh4 titers in blood serum were quantita- 
tively evaluated by the value of the ratio between sample optical 
density (OD) and cut-off level. 
Comparison of mean OD values per month with monthly dy- 
namics in HA morbidity revealed a relatively low correlation ratio 
for an epidemic year in general (r = 0.46). Yet OD values were min- 
imal in July when morbimty rates were at the lowest, while increase 
waves in August and October 1995 coincided on both plots. Lower 
OD values in September and October corresponded to stabilization 
of the number of the patients idenhfied during these months. Hence 
from July to November, i.e. during season rise, a strong correlation (r 
= 0.74) was revealed between monthly values of HA morbidity and 
anti-HAVIgM titers in patients blood sera. However, a continually 
increasing morbidity in December was accompanied by a decrease 
in mean values of OD samples relative to cut off level. 
Thus starting h m  November, OD values indirectly reflecting 
patients responses to HAV invasion cease to follow morbidity dy- 
namics which may be regarded as a decrease in the agent's virulence 
even before season morbimty peak. This is a favourable predicting 
circumstance, permitting the use of anti-HAVIgM titer variations 
in quantitative evaluation of EIA results for prompt epidemiologic 
analysis. 
RNA Replication and Polyprotein Processing of 
Hepatitis A Virus (HAV) in FRhM Cells 
R. b e r e r ,  B. Hornei, C. Probst, V. Gauss-Miiller. Institute of 
Medical Microbiology and Hygiene, Medical University of Ldbeck, Ldbeck, 
Germany 
Objectives: Hepatitis A virus is an atypical picornavirus causing 
considerable morbidity in adults. Due to the virus' slow p w t h  
Hepatitis B and miscellaneous 
Prevalence for Hepatitis B and C in Sexually 
Active Men by Unlinked Anonymous Testing 
(UAT) of Condom Semen Samples 
P Vernazza, L.A. Pfister, W Fierz, J. Osterwalder. Kantonsspital and 
I kMI ,  St. Gallen, Switzerland 
Objective: To evaluate the use of condom semen sample for sero- 
logic monitoring for Hepatitis B and Hepatitis C by UAT in order 
to extend our previously reported findings on UAT for HIV with 
this procedure 
Methods: Seminal plasma was obtained h m  condoms used by 
prostitutes in eastern Switzerland. Sensitivity and specificity of com- 
mercially available serologic tests for HBV and HCV in seminal 
plasma were established with semen samples h m  subjects with 
known blood serology. A total of 804 condom semen samples were 
available for testing 
Results: Sensitivity of the serologic tests applied was 75% for 
HBV (antiHB, I&, Axsym Core, Abbott), and 87% for HCV 
(Axsym HCV, Abbott). The spenficity of both assays in seminal 
plasma was 100%. Results of the condom semen sample testing are 
given in the table. 
Anubody Test N tested N positive Prevalence 95% CI 
and-HB,-IgG 749 21 2.8% 154.6% 
ma-HIV 804 0 0% a-o.54% 
ano-HCV-IgG 559 8 1.4% 0.5-3.0% 
Conclusion: The method of UAT of condom semen samples is 
applicable for the epidemiologic monitoring of the prevalence of 
Hepatitis B and C. Given the low sensitivity of the method (which 
is object to further improvements) the results underestimate the true 
prevalence. 
